Description
Composition Olaparib 150mg
Substitutes Lynparza 150mg
Medicine Overview of Bracanat (Olaparib)
Uses of Bracanat (Olaparib)
Olanib (Olaparib) is a prescription medicine used to treat adult women who are in the advanced ovarian cancer stage.
Bracanat (Olaparib) side effects
Common
Decreased hemoglobin, Fatigue/asthenia, Nausea, Mean corpuscular volume elevation, Decreased lymphocytes, Abdominal pain/discomfort, Vomiting, Anemia, Diarrhea, Increased serum creatinine, Decreased platelets, Nasopharyngitis/URTI, Dyspepsia, decreased ANC, Decreased appetite, Myalgia, Arthralgia/musculoskeletal pain, Hypersensitivity (rash, dermatitis), Cough, Thrombocytopenia, Dysgeusia, Lymphopenia, Dizziness, Stomatitis, Upper abdominal pain.
How to use Bracanat (Olaparib)
For advanced Ovarian cancer, 8 capsules twice daily (400 mg per dose) with or without food. Olanib (Generic Olaparib) dosages must be taken according to professional physician??s instructions. Dosages may vary according to patient conditions.
How Bracanat (Olaparib) works
FDA approves Olaparib for the treatment of patients with germline BRCA-positive, HER2-negative metastatic breast cancer who have previously received chemotherapy.
Bracanat (Olaparib) related warnings
Special precautions for Bracanat (Olaparib)
Alcohol
Interaction with alcohol is unknown. Please consult your doctor.
Pregnancy
WEIGH RISKS VS BENEFITS
Bracanat (Olaparib) is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Lactation
CAUTION
Bracanat (Olaparib) is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Driving
It is not known whether Bracanat (Olaparib) alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
Bracanat (Olaparib) is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Bracanat (Olaparib) may not be needed in these patients. Please consult your doctor.
Liver
There is limited information available on the use of Bracanat (Olaparib) in patients with liver disease. Please consult your doctor.
